港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

抗疫概念

921.061

-16.610-1.77%

漲家數：6

跌家數：12

平家數：- -

市盈率：- -

高：937.645

開：937.393

低：917.294

收：937.672

資料載入中...

總覽新聞資訊

白雲山獲融資買入0.12億元，近三日累計買入0.48億元

比亞迪即將推出的新款微型電動車成日本車企 “巨大威脅”！

汽车产业前线观察

華陽智能股東復星惟盈擬減持不超5%公司股份

瑞康醫藥：股東荊州慧澤擬減持不超1%公司股份

【瑞康醫藥：荊州慧澤擬減持不超1%公司股份】瑞康醫藥公告，公司持股5%以上股東荊州招商慧澤醫藥投資合夥企業計劃以集中競價交易或大宗交易方式減持不超過1504.71萬股，佔公司總股本的1%。

中國—白俄羅斯政府間合作委員會經貿合作分委會第九次會議在京召開

皮膚學級護膚品公司德鎂醫藥擬在香港衝刺IPO

经济观察网

中國生物製藥與京東健康深化戰略合作，借數字醫療打破信息壁壘

新康獨家 | 2025AACR專訪：君實生物醫學科學副總裁楊清

阿里健康5月19日舉行董事會會議考慮及通過全年業績

同源康醫藥-B05月07日主力淨流出267.7萬元散戶資金買入

中國生物製藥05月07日主力淨流出1944.5萬元散戶資金買入

四環醫藥05月07日主力淨流出47.5萬元散戶資金買入

平安好醫生05月07日主力淨流入142.1萬元散戶資金拋售

東陽光長江藥業05月07日獲主力加倉258.9萬元

中國中藥05月07日獲主力加倉1712.4萬元

港股收盤，恒指收漲0.13%，科指收跌0.75%；中升控股(00881.HK)漲近5%，友邦保險(01299.HK)漲近

中國生物製藥(01177)下跌3.29%，報3.82元/股

創新藥概念持續調整百濟神州跌7.31% 機構指醫藥板塊中最值得關注的仍是創新藥賽道

歌禮制藥-B盤中異動下午盤股價大跌5.02%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1515/news?page=13"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":921.0613,"timestamp":1747291502163,"preClose":937.6715,"halted":0,"volume":228079232,"delay":0,"changeRate":-0.017714,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-16.610229,"latestTime":"05-15 14:45:02","open":937.39325,"high":937.6448,"low":917.29376,"amount":1642489770,"amplitude":0.021704,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1747296600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1747272600000,1747281600000],[1747285200000,1747296000000]],"pbRate":1.633562,"peRate":21.843761,"turnoverRate":0.003099,"increases":6,"decrements":12,"flats":0,"marketCap":632738018112,"floatMarketCap":522548836800},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":937.6448,"amplitude":0.021704,"preClose":937.6715,"low":917.29376,"pbRate":"1.633562","latestPrice":921.0613,"volume":228079232,"delay":0,"open":937.39325,"prevYearClose":787.97723,"prevWeekClose":896.528,"prevMonthClose":903.998,"prevQuarterClose":870.015,"fiveDayClose":907.789,"twentyDayClose":840.443,"sixtyDayClose":887.079,"secType":"PLATE","market":"HK","turnoverRate":0.003099,"peRate":21.843761,"marketCap":632738018112,"floatMarketCap":522548836800,"timestamp":1747291502163,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":6,"down":12,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:13,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533994417","title":"白雲山獲融資買入0.12億元，近三日累計買入0.48億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533994417","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533994417?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 08:02","pubTimestamp":1746662556,"startTime":"0","endTime":"0","summary":"5月7日，沪深两融数据显示，白云山获融资买入额0.12亿元，居两市第1012位，当日融资偿还额0.15亿元，净卖出264.66万元。最近三个交易日，30日-7日，白云山分别获融资买入0.19亿元、0.17亿元、0.12亿元。融券方面，当日融券卖出0.20万股，净买入0.16万股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/08080250210365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0070","BK0096","BK0196","BK1197","BK0183","BK0239","BK1191","00874","BK0097","BK1521","BK0175","BK1515","600332","BK0012","BK0188","BK1606","BK0028"],"gpt_icon":0},{"id":"2533992702","title":"比亞迪即將推出的新款微型電動車成日本車企 “巨大威脅”！","url":"https://stock-news.laohu8.com/highlight/detail?id=2533992702","media":"汽车产业前线观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533992702?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 07:41","pubTimestamp":1746661290,"startTime":"0","endTime":"0","summary":"比亚迪计划推出的这款新微型电动车属于轻型车范畴，作为价格低廉的选择，它极有可能对日本的汽车制造商构成 “巨大威胁”。比亚迪的新款微型电动车预计于 2026 年在日本亮相。比亚迪的微型电动车方面，去年轻型车在日本新车销量中占比约 40%，总销量约为 155 万辆。比亚迪新款微型电动车的预计起售价约为 260 万日元，折合约 1.8 万美元。上个月，比亚迪推出了新款中型智能电动 SUV 海狮 7，起售价为 495 万日元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508080822a6d6ec31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508080822a6d6ec31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","LU2778985437.USD","002594","BK1607","HYDD.SI","81211","LU0543330566.HKD","LU0634319403.HKD","LU0979878070.USD","LU0516422366.SGD","LU1861219969.SGD","LU0509642566.USD","LU0572944931.SGD","BK1580","LU1251922891.USD","LU0823414478.USD","LU0449509016.USD","LU0315178854.USD","LU0289961442.SGD","LU0043850808.USD","LU0289960550.SGD","BK1594","BYDDY","BK1515","LU1023057109.AUD","LU0516423091.SGD","BK1504","LU0516422440.USD","LU2476274308.USD","LU0175139822.USD","LU0214875030.USD","LU0269904917.USD","LU0856984785.SGD","SG9999006514.SGD","00285","LU0165289439.USD","01211","SG9999015952.SGD","SG9999001226.SGD","LU0865486749.SGD","BK1582","LU0211977185.USD","SG9999002463.SGD","LU0348825331.USD","LU0054450605.USD","LU0348767384.USD","LU0828238088.HKD","LU0359202008.SGD","SG9999006597.SGD","LU0531971595.HKD"],"gpt_icon":1},{"id":"2533957906","title":"華陽智能股東復星惟盈擬減持不超5%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2533957906","media":"北京商报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533957906?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 22:50","pubTimestamp":1746629450,"startTime":"0","endTime":"0","summary":"北京商报讯（记者 马换换 王蔓蕾）5月7日晚间，华阳智能（301502）披露公告称，持有14.25%公司股份的股东宁波梅山保税港区复星惟盈股权投资基金合伙企业（有限合伙）（以下简称“复星惟盈”）计划在公告披露之日起15个交易日后的3个月内以集中竞价和大宗交易方式减持不超过5%公司股份。华阳智能表示，复星惟盈不属于公司控股股东、实际控制人，本次减持计划的实施不会影响公司的治理结构和持续经营，不会导致公司控制权发生变更。交易行情显示，截至5月7日收盘，华阳智能股价报37.89元/股，总市值21.63亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507225056975214e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507225056975214e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1191","02196","BK1515"],"gpt_icon":0},{"id":"2533893111","title":"瑞康醫藥：股東荊州慧澤擬減持不超1%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2533893111","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533893111?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 22:15","pubTimestamp":1746627317,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1574","BK0077","BK0250","BK0070","002589","BK0185","BK0197","BK1161","BK1515","159938","09939","BK0132"],"gpt_icon":0},{"id":"2533294936","title":"【瑞康醫藥：荊州慧澤擬減持不超1%公司股份】瑞康醫藥公告，公司持股5%以上股東荊州招商慧澤醫藥投資合夥企業計劃以集中競價交易或大宗交易方式減持不超過1504.71萬股，佔公司總股本的1%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533294936","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533294936?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 21:42","pubTimestamp":1746625337,"startTime":"0","endTime":"0","summary":"瑞康医药公告，公司持股5%以上股东荆州招商慧泽医药投资合伙企业计划以集中竞价交易或大宗交易方式减持不超过1504.71万股，占公司总股本的1%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/07214250207933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0077","BK0185","BK1515","002589","BK0132","BK0070","BK0197","BK0250","BK1161","BK1574","09939","159938"],"gpt_icon":0},{"id":"2533935224","title":"中國—白俄羅斯政府間合作委員會經貿合作分委會第九次會議在京召開","url":"https://stock-news.laohu8.com/highlight/detail?id=2533935224","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533935224?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 21:38","pubTimestamp":1746625097,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["09996","BK1583","BK1222","BK1100","159938","BK1515","BK1161","BK1574","09939","09997","159883"],"gpt_icon":0},{"id":"2533934924","title":"皮膚學級護膚品公司德鎂醫藥擬在香港衝刺IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2533934924","media":"经济观察网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533934924?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 19:05","pubTimestamp":1746615900,"startTime":"0","endTime":"0","summary":"公司动态近期，港交所上市企业康哲药业发布公告称，计划将旗下专注于皮肤业务的子公司德镁医药的股份进行分拆，并在香港联交所主板实现独立上市。公告表明，康哲药业持有德镁医药90.8%的股权，其余9.2%的股权由两家雇员激励平台持有。据了解，德镁医药在2024年的营收超过了6亿元。此外，该公司于2022年进军皮肤学级护肤品赛道，目前相关业务收入在公司总收入中的占比已超过10%。截至目前尚未有皮肤学级护肤品企业成功在港交所上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-05-07/doc-inevtyiw1051440.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-05-07/doc-inevtyiw1051440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","BK1515","BK1574","09939","BK1161"],"gpt_icon":0},{"id":"2533748216","title":"中國生物製藥與京東健康深化戰略合作，借數字醫療打破信息壁壘","url":"https://stock-news.laohu8.com/highlight/detail?id=2533748216","media":"新京报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533748216?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 16:55","pubTimestamp":1746608144,"startTime":"0","endTime":"0","summary":"新京报讯（记者王卡拉）5月6日，中国生物制药与京东健康宣布，全面深化战略合作，双方将围绕全品类供应链、全渠道零售及创新营销模式等领域展开深度合作。中国生物制药表示，与京东健康的合作，是公司打通药品普惠“最后一公里”的关键举措，希望通过数字医疗打破信息壁垒，突破地域限制，让患者以更快速度获得更多好药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505073398152015.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505073398152015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["86618","BK1515","LU0051755006.USD","06618","BK1191","BK1247","BK1591","LU0456827905.SGD","BK1521","01177","BK1583","BK1142","BK1589","BK1615","BK1571"],"gpt_icon":0},{"id":"2533367937","title":"新康獨家 | 2025AACR專訪：君實生物醫學科學副總裁楊清","url":"https://stock-news.laohu8.com/highlight/detail?id=2533367937","media":"新康界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533367937?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 16:55","pubTimestamp":1746608111,"startTime":"0","endTime":"0","summary":"为进一步挖掘君实生物的研发布局，新康界特邀君实生物医学科学副总裁杨清进行深入交流。阮丹云教授在2025 AACR大会上做口头报告“JS107是君实生物自主研发的1类新药，由重组人源化抗CLDN18.2单克隆抗体裸蛋白通过vc-PAB的马来酰亚胺连接体偶联MMAE而成。”相较全球同类药物如阿斯利康的CLDN18.2单抗Zolbetuximab，JS107通过ADC技术放大了杀伤效应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224320a6d67962&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224320a6d67962&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1515","BK1161","688180","BK1583"],"gpt_icon":0},{"id":"2533501679","title":"阿里健康5月19日舉行董事會會議考慮及通過全年業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2533501679","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533501679?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 16:40","pubTimestamp":1746607227,"startTime":"0","endTime":"0","summary":"格隆汇5月7日丨阿里健康(00241.HK)宣布，董事会将于2025年5月19日(星期一)举行董事会会议，旨在考虑及通过(其中包括)公司及其附属公司截至2025年3月31日止年度的全年业绩，以及考虑建议派付末期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507164027a6d61609&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507164027a6d61609&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1142","BK1247","00241","BK1502","BK1501","BK1515","BK1571","BK1589","BK1617","BK1591","BK1615","BK1584","BK1189","BK1610"],"gpt_icon":0},{"id":"2533061376","title":"同源康醫藥-B05月07日主力淨流出267.7萬元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2533061376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533061376?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 16:15","pubTimestamp":1746605736,"startTime":"0","endTime":"0","summary":"05月07日, 同源康医药-B股价跌3.33%，报收31.90元，成交金额8492.9万元，换手率0.73%，振幅6.67%，量比0.73。同源康医药-B今日主力资金净流出267.7万元，上一交易日主力净流入524.0万元。该股近5个交易日上涨13.37%，主力资金累计净流入1137.8万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入5957.5万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507171304a4752270&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507171304a4752270&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","09939","BK1515","BK1574","BK1161"],"gpt_icon":0},{"id":"2533560653","title":"中國生物製藥05月07日主力淨流出1944.5萬元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2533560653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533560653?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 16:15","pubTimestamp":1746605731,"startTime":"0","endTime":"0","summary":"05月07日, 中国生物制药股价跌3.04%，报收3.83元，成交金额4.1亿元，换手率0.57%，振幅5.32%，量比1.50。中国生物制药今日主力资金净流出1944.5万元，上一交易日主力净流入1512.7万元。该股近5个交易日下跌0.26%，主力资金累计净流出4503.6万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入8784.4万元，其中净流入天数为11日。该股主力净额占比0.03%，港股市场排名2478/2646。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507171129a47521db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507171129a47521db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","BK1521","BK1191","01177","BK1515"],"gpt_icon":0},{"id":"2533674090","title":"四環醫藥05月07日主力淨流出47.5萬元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2533674090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533674090?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 16:15","pubTimestamp":1746605730,"startTime":"0","endTime":"0","summary":"05月07日, 四环医药股价跌2.70%，报收0.72元，成交金额2517.1万元，换手率0.37%，振幅5.41%，量比0.73。四环医药今日主力资金净流出47.5万元，上一交易日主力净流入488.1万元。该股近5个交易日上涨4.35%，主力资金累计净流入1954.7万元；近20日主力资金累计净流入4760.3万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507171104a47521b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507171104a47521b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","BK1191","00460","BK1593","BK1515"],"gpt_icon":0},{"id":"2533667281","title":"平安好醫生05月07日主力淨流入142.1萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2533667281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533667281?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 16:15","pubTimestamp":1746605726,"startTime":"0","endTime":"0","summary":"05月07日, 平安好医生股价涨1.76%，报收7.53元，成交金额5030.1万元，换手率0.31%，振幅3.11%，量比0.94。平安好医生今日主力资金净流入142.1万元，上一交易日主力净流出322.8万元。该股近5个交易日上涨4.83%，主力资金累计净流入232.3万元；近20日主力资金累计净流入1957.9万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507170959a6d62002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507170959a6d62002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1142","BK1219","BK1571","01833","BK1247","BK1617","BK1515","BK1615"],"gpt_icon":0},{"id":"2533672864","title":"東陽光長江藥業05月07日獲主力加倉258.9萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533672864","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533672864?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 16:15","pubTimestamp":1746605724,"startTime":"0","endTime":"0","summary":"05月07日, 东阳光长江药业股价涨0.31%，报收12.90元，成交金额4061.2万元，换手率0.48%，振幅2.33%，量比0.59。东阳光长江药业今日主力资金净流入258.9万元，上一交易日主力净流入625.1万元。该股近5个交易日上涨5.56%，主力资金累计净流入430.1万元；近20日主力资金累计净流入980.4万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507170916a4752101&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507170916a4752101&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01558"],"gpt_icon":0},{"id":"2533740196","title":"中國中藥05月07日獲主力加倉1712.4萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533740196","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533740196?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 16:15","pubTimestamp":1746605723,"startTime":"0","endTime":"0","summary":"05月07日, 中国中药股价涨1.96%，报收2.08元，成交金额7963.2万元，换手率0.76%，振幅2.94%，量比2.33。中国中药今日主力资金净流入1712.4万元，上一交易日主力净流入554.8万元。该股近5个交易日上涨1.98%，主力资金累计净流入3041.9万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入9908.3万元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507170854a47520e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507170854a47520e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00570","BK1606","BK1191","BK1515"],"gpt_icon":0},{"id":"2533673551","title":"港股收盤，恒指收漲0.13%，科指收跌0.75%；中升控股(00881.HK)漲近5%，友邦保險(01299.HK)漲近","url":"https://stock-news.laohu8.com/highlight/detail?id=2533673551","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533673551?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 16:09","pubTimestamp":1746605370,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d308e1e0dcbd1f45bcee5ecd29af9255","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["HSI","LU0348825331.USD","00881","LU0456842615.SGD","LU0106259558.USD","LU1481107354.HKD","LU0315179316.USD","YANG","BK1184","LU2039709279.SGD","07226","02269","LU2177674079.SGD","BK1515","LU0588545490.SGD","HSCEI","LU0067412154.USD","IE00B031HY20.USD","LU1794554557.SGD","LU0128522157.USD","MCHmain","AAGIY","02319","01177","81299","LU0588545730.USD","LU0865486749.SGD","01299","LU1804176565.USD","LU0320764755.SGD","02833","HSTECH","SG9999001689.USD","513600","LU0557290698.USD","LU0886674414.USD","LU1504937902.USD","LU0737861699.HKD","LU0235996351.USD","HHImain","MHImain","SG9999011746.SGD","SG9999002828.SGD","LU2153592121.USD","LU1642822792.SGD","LU0577902611.USD","LU0164880469.USD","HSImain","SG9999000459.SGD","LU2348773727.SGD"],"gpt_icon":0},{"id":"2533296606","title":"中國生物製藥(01177)下跌3.29%，報3.82元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533296606","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533296606?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 14:21","pubTimestamp":1746598890,"startTime":"0","endTime":"0","summary":"5月7日，中国生物制药盘中下跌3.29%，截至14:21，报3.82元/股，成交3.0亿元。中国生物制药有限公司是一家创新研究和研发驱动型的医药集团，其主要业务包括医药研发、智能化生产以及销售，主要产品包括多种生物药和化学药，特别在肿瘤、肝病、呼吸系统、外科/镇痛四大治疗领域具有优势。截至2024年年报，中国生物制药营业总收入288.66亿元、净利润35.0亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/07142150188037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","BK1521","BK1515","BK1589","01177"],"gpt_icon":0},{"id":"2533462501","title":"創新藥概念持續調整 百濟神州跌7.31% 機構指醫藥板塊中最值得關注的仍是創新藥賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2533462501","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533462501?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 14:03","pubTimestamp":1746597782,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念持续调整，加科思 跌13.95%，百济神州跌7.31%，君实生物跌6.75%，荣昌生物跌6.6%，药明生物跌6.24%。国金证券研报指，医药板块中最值得关注的仍将是创新药赛道，该行认为对创新医药投资机会的把握将是贯穿2025年全年医药投资的主线，在当前时点重点看好创新药出海龙头和仿创结合龙头，同时积极关注会议数据发布和海外BD商务合作进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050714034194eedfd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050714034194eedfd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1588","LU2328871848.SGD","06160","BK1574","09939","BK1161","LU0588546209.SGD","LU0307460666.USD","BK1500","LU1969619763.USD","BK1583","06978"],"gpt_icon":0},{"id":"2533625702","title":"歌禮制藥-B盤中異動 下午盤股價大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533625702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533625702?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 13:54","pubTimestamp":1746597287,"startTime":"0","endTime":"0","summary":"2025年05月07日下午盘13时54分，歌礼制药-B股票出现异动，股价大幅下跌5.02%。截至发稿，该股报6.250港元/股，成交量132万股，换手率0.14%，振幅8.36%。机构评级方面，在所有4家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。歌礼制药-B股票所在的生物技术行业中，整体跌幅为4.43%。歌礼制药-B公司简介：歌礼制药有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507135447a474e995&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507135447a474e995&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1574","BK1191","BK1515","BK1161","01477"],"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":13,"totalSize":350,"code":"91000000","status":"200"}]}}